Azithromycin for Diarrhea

Introduction to Azithromycin Use

The American College of Physicians and the Infectious Diseases Society of America recommend azithromycin for bacterial diarrhea, to be used selectively based on severity, clinical presentation, and travel history, not routinely for all diarrhea cases 1, 2

The Centers for Disease Control and Prevention advise against empiric antimicrobial therapy, including azithromycin, for most acute watery diarrhea without recent international travel, due to the high likelihood of self-limited viral or mild bacterial infections, and the risk of driving antimicrobial resistance 1, 2, 3
Azithromycin should be avoided in patients with persistent watery diarrhea lasting ≥14 days, as noninfectious etiologies such as inflammatory bowel disease, irritable bowel syndrome, or lactose intolerance become more likely 1, 2
The use of azithromycin is not recommended for STEC O157 or Shiga toxin 2-producing E. coli infections, as antibiotics may worsen outcomes 1, 2

The World Health Organization recommends azithromycin as the preferred empiric agent for bloody diarrhea with fever, particularly when Shigella or Campylobacter is suspected, due to its high efficacy and safety profile 1, 2, 4
Azithromycin is indicated for ill patients with documented fever, abdominal pain, bloody diarrhea, and bacillary dysentery, as well as for recent international travelers with temperature ≥38.5°C and/or signs of sepsis 1, 2
The American Academy of Pediatrics recommends azithromycin for infants <3 months with suspected bacterial etiology, though a third-generation cephalosporin is preferred if neurologic involvement is suspected 1, 2

The Infectious Diseases Society of America recommends a single 1000 mg dose of azithromycin for better compliance, though 500 mg daily for 3 days is equally effective, with a strong recommendation based on high-quality evidence 4, 5, 3

The European Society of Clinical Microbiology and Infectious Diseases recommends combining azithromycin with loperamide for faster symptomatic relief in moderate-to-severe cases without contraindications, with a moderate strength of evidence 4, 3

The Centers for Disease Control and Prevention advise that travel history fundamentally changes antibiotic selection, with azithromycin being mandatory first-line in Southeast Asia and India due to high fluoroquinolone resistance 1, 2, 4

Azithromycin demonstrates excellent activity against Campylobacter, with 100% cure rates, superior to fluoroquinolones in resistant areas, based on high-quality evidence 4
The World Health Organization reports that azithromycin is an effective first-line treatment for Shigella, with comparable cure rates, based on moderate-quality evidence 4, 5

The American College of Gastroenterology warns of gastrointestinal side effects, including nausea, which occurs in approximately 3-8% of patients, more common with 1000 mg dose than 500 mg, based on low-quality evidence 5
The Infectious Diseases Society of America advises against administering azithromycin simultaneously with aluminum or magnesium-containing antacids, as they reduce absorption, based on high-quality evidence 5

The European Society of Clinical Microbiology and Infectious Diseases recommends assessing severity, checking for bloody diarrhea or fever ≥38.5°C, evaluating travel history, considering host factors, choosing regimen, adding loperamide if necessary, and reassessing at 24-36 hours, with a strong recommendation based on high-quality evidence 3, 1, 2, 4